Agentic AI in Cancer Research
To Know
About this Class
Agentic AI is a class of artificial intelligence that acts autonomously to make decisions and take actions to achieve specific goals. During this event, the participants will discuss the emerging role of AI agents as intelligent partners in cancer research.
The virtual Cancer AI Conversations Series features perspectives on timely topics and themes in artificial intelligence for cancer research.
Each event features short talks from a panel of subject matter experts, offering diverse views on the session topic. These talks are followed by a moderated panel discussion.
Moderator: Anwesha Dey, Ph.D., Genentech
Panelists: James Zou, Ph.D., Stanford University and Vivek Natarajan, Ph.D., Google
Additional information can be found on the Cancer AI Conversations website.
If you are an individual with a disability who needs reasonable accommodations to participate in this event, please contact Dr. Juli Klemm at your earliest convenience.